Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DCGO NASDAQ:KDLY NASDAQ:TOI NASDAQ:VMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDCGODocGo$1.46+2.5%$1.51$1.23▼$5.68$148.39M0.97753,145 shs225,914 shsKDLYKindly MD$11.41-3.1%$15.38$0.65▼$34.77$68.71MN/A2.24 million shs476,778 shsTOIOncology Institute$3.66+13.2%$2.71$0.13▼$3.76$328.65M0.021.21 million shs3.48 million shsVMDViemed Healthcare$6.64-0.7%$6.75$6.14▼$9.81$262.44M1.37145,671 shs124,234 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDCGODocGo+2.16%-8.97%-7.79%-33.02%-58.24%KDLYKindly MD-2.65%-8.83%-14.71%+572.57%+396.62%TOIOncology Institute+8.75%+33.47%+32.38%+49.54%+555.17%VMDViemed Healthcare+1.06%-4.15%-0.89%+0.90%-7.21%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDCGODocGo2.1979 of 5 stars3.31.00.00.02.72.50.6KDLYKindly MDN/AN/AN/AN/AN/AN/AN/AN/ATOIOncology Institute2.0093 of 5 stars3.82.00.00.02.50.80.0VMDViemed Healthcare1.2376 of 5 stars0.02.00.00.01.63.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDCGODocGo 2.50Moderate Buy$3.56144.67% UpsideKDLYKindly MD 0.00N/AN/AN/ATOIOncology Institute 3.50Strong Buy$6.5077.74% UpsideVMDViemed Healthcare 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest KDLY, VMD, TOI, and DCGO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/16/2025TOIOncology InstituteB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$6.007/15/2025TOIOncology InstituteB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/15/2025TOIOncology InstituteBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$7.005/12/2025DCGODocGoCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$5.00 ➝ $1.455/9/2025DCGODocGoNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$4.00 ➝ $3.005/9/2025DCGODocGoBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDCGODocGo$520.50M0.29$0.44 per share3.29$3.09 per share0.47KDLYKindly MD$2.47M27.81N/AN/AN/A∞TOIOncology Institute$403.15M0.81N/AN/A$0.05 per share73.14VMDViemed Healthcare$232.79M1.13$0.94 per share7.04$3.41 per share1.95Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDCGODocGo$19.99M-$0.02N/A18.19N/A-0.12%2.52%1.70%8/6/2025 (Estimated)KDLYKindly MDN/A-$0.77N/A∞N/AN/AN/AN/AN/ATOIOncology Institute-$64.66M-$0.70N/A∞N/A-15.38%-445.02%-34.13%8/12/2025 (Estimated)VMDViemed Healthcare$11.27M$0.3022.13∞N/A5.28%9.49%7.14%8/6/2025 (Estimated)Latest KDLY, VMD, TOI, and DCGO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025DCGODocGo-$0.06N/AN/AN/A$77.58 millionN/A5/14/2025Q1 2025TOIOncology InstituteN/A-$0.18N/A-$0.21N/A$104.41 million5/8/2025Q1 2025DCGODocGo-$0.01-$0.09-$0.08-$0.09$104.25 million$96.03 million5/8/2025Q1 2025KDLYKindly MDN/A-$0.17N/A-$0.17N/AN/A5/7/2025Q1 2025VMDViemed Healthcare$0.06$0.06N/A$0.06$60.60 million$59.10 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDCGODocGoN/AN/AN/AN/AN/AKDLYKindly MDN/AN/AN/AN/AN/ATOIOncology InstituteN/AN/AN/AN/AN/AVMDViemed HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDCGODocGoN/A2.442.44KDLYKindly MDN/A5.435.42TOIOncology Institute14.581.791.59VMDViemed Healthcare0.031.381.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDCGODocGo56.44%KDLYKindly MDN/ATOIOncology Institute36.86%VMDViemed Healthcare74.24%Insider OwnershipCompanyInsider OwnershipDCGODocGo2.70%KDLYKindly MD50.50%TOIOncology Institute8.50%VMDViemed Healthcare20.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDCGODocGo4,407101.98 million99.23 millionOptionableKDLYKindly MDN/A6.02 million2.96 millionN/ATOIOncology Institute66089.23 million81.65 millionNot OptionableVMDViemed Healthcare1,17939.52 million31.62 millionNot OptionableKDLY, VMD, TOI, and DCGO HeadlinesRecent News About These CompaniesLafayette’s Viemed completes $26 million acquisition of Illinois medical equipment firmJuly 9, 2025 | theadvertiser.comTViemed officially adds Lehan’s to familyJuly 7, 2025 | hmenews.comHViemed Healthcare (NASDAQ:VMD) Stock Price Up 1.2% - Time to Buy?July 4, 2025 | marketbeat.comViemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial ResultsJuly 2, 2025 | accessnewswire.comAInsider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 8,852 Shares of StockJuly 1, 2025 | insidertrades.comInsider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 8,852 Shares of StockJune 30, 2025 | marketbeat.comInsider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 34,100 Shares of StockJune 30, 2025 | marketbeat.comViemed Healthcare: Getting More AirJune 25, 2025 | seekingalpha.comviemed healthcare shareholders approve key amendments and director electionsJune 7, 2025 | investing.comViemed Healthcare, Inc. (VMD): A Bull Case TheoryMay 14, 2025 | finance.yahoo.comViemed Healthcare, Inc. (VMD) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comLake Street Keeps Their Buy Rating on Viemed Healthcare (VMD)May 9, 2025 | theglobeandmail.comViemed Healthcare Inc (VMD) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...May 9, 2025 | finance.yahoo.comViemed Healthcare, Inc. Announces Definitive Agreement to Acquire Lehan's Medical EquipmentMay 8, 2025 | nasdaq.comViemed Healthcare, Inc. Reports Q1 2025 Financial Results and Updates Full Year GuidanceMay 7, 2025 | quiverquant.comQViemed Healthcare Announces First Quarter 2025 Financial ResultsMay 7, 2025 | globenewswire.comViemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in IllinoisMay 6, 2025 | globenewswire.comViemed Healthcare Announces First Quarter 2025 Earnings Conference Call DetailsApril 22, 2025 | globenewswire.comViemed Healthcare, Inc. (VMD): A Bull Case TheoryMarch 28, 2025 | insidermonkey.comViemed stays ‘nimble’March 15, 2025 | hmenews.comHIn Lafayette, health care jobs continue to rise. VieMed is a key reason why.March 13, 2025 | theadvocate.comTNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKDLY, VMD, TOI, and DCGO Company DescriptionsDocGo NASDAQ:DCGO$1.46 +0.04 (+2.46%) As of 03:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Kindly MD NASDAQ:KDLY$11.41 -0.36 (-3.06%) As of 07/16/2025Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.Oncology Institute NASDAQ:TOI$3.66 +0.43 (+13.22%) As of 03:05 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.Viemed Healthcare NASDAQ:VMD$6.64 -0.05 (-0.75%) As of 03:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
